Action 2877 CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues China Shineway Pharmaceutical Group Limited

Actions

2877

KYG2110P1000

Marché Fermé - Hong Kong S.E.
Autres places de cotation
 10:08:09 16/05/2024 		Varia. 5j. Varia. 1 janv.
9,47 HKD -4,25% Graphique intraday de China Shineway Pharmaceutical Group Limited +3,05% +30,26%
29/03 China Shineway Pharmaceutical Group augmente ses bénéfices en 2023 et déclare un dividende intérimaire pour 2024 MT
28/03 China Shineway Pharmaceutical Group Limited publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
China Shineway Pharmaceutical Group Grows 2023 Profit, Declares Interim 2024 Dividend
China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
China Shineway Pharmaceutical Group Limited Declares First Interim Dividend in Respect of the Year Ending December 31, 2024, Payable on May 17, 2024
China Shineway Pharmaceutical to Log Higher Profit in 2023; Shares Up 3%
China Shineway Pharmaceutical Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023
​​China Shineway Pharmaceutical Logs 22% Rise in Q1-Q3 Turnover
China Shineway Pharmaceutical Group Limited Announces Resignation of Executive Director
China Shineway Pharmaceutical Group Limited Announces Resignation of Liu Tiejun as Executive Director, Effective 1 November 2023
China Shineway Pharmaceutical’s Profit Rises 48% in H1
China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023
China Shineway Pharmaceutical Group Limited Proposes Second Interim Dividend in Respect of the Fiscal Year 2023, Payable on 29 September 2023
China BlueChemical, Unit to Invest in Structured Deposit Products
China Shineway Pharmaceutical’s H1 Profit to Rise By Up to 50%
China Shineway Pharmaceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
Bank of China Raises 30 Billion Yuan with Bond Issue
Shineway Pharmaceutical's Q1 Turnover Rises 36%
China Shineway Pharmaceutical Group's 2022 Profit Jumps 29.8%
China Shineway Pharmaceutical Group Limited Announces First Interim Dividend in Respect of the Fiscal Year 2023, Payable on 17 May 2023
China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022
China Shineway Pharmaceutical Group Limited Announces Board Changes
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 2877
  4. Actualités China Shineway Pharmaceutical Group Limited
  5. Autres langues